Inspiro Medical

Company Overview

Snapshot

Founded in November 2010 by Guy Steuer, Inspiro Medical operated with 1–10 employees. The company was acquired by OPKO Health in April 2014, marking a significant exit in the medical device sector.

Business overview

Inspiro Medical was a medical device company focused on developing an inhalation platform for delivering small molecules like corticosteroids or beta agonists, as well as macromolecules such as antibodies or vaccines. Its core product, Inspiromatic, was a dry powder inhaler (DPI) designed to overcome the limitations of existing inhalers by combining an active dry powder fluidization mechanism with real-time feedback control. This technology aimed to ensure optimal drug delivery, particularly benefiting young children and the elderly. The company operated within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Drug Delivery markets.

Strategic signal

In April 2014, Inspiro Medical was acquired by OPKO Health for at least $10 million, signaling a successful exit for the medical device startup. This acquisition validated Inspiro Medical's innovative dry powder inhaler technology and demonstrated the strategic interest of larger pharmaceutical companies in advanced drug delivery systems, particularly those addressing challenges in patient adherence and optimal dosage.

Company Intelligence Q&A

When was Inspiro Medical founded?

Inspiro Medical was founded in November 2010.

Who founded Inspiro Medical?

Inspiro Medical was founded by Guy Steuer.

What was a key product developed by Inspiro Medical?

Inspiro Medical developed Inspiromatic, a dry powder inhaler (DPI) designed for optimal drug delivery.

When was Inspiro Medical acquired and by whom?

Inspiro Medical was acquired by OPKO Health in April 2014.

What was the reported acquisition amount for Inspiro Medical?

OPKO Health acquired Inspiro Medical for at least $10 million in April 2014, according to news reports from Globes and MobiHealthNews.